International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease
February 16, 2026
February 16, 2026
BIRMINGHAM, Alabama, Feb. 16 -- The University of Alabama issued the following news:
* * *
International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease
*
Obstructive hypertrophic cardiomyopathy is a leading cause of heart-related disability in younger adults and the most common cause of sudden death in young athletes. Researchers from the University of Alabama at Birmingham Marn . . .
* * *
International study shows mavacamten monotherapy improves heart function in patients with HCM, a common inherited heart disease
*
Obstructive hypertrophic cardiomyopathy is a leading cause of heart-related disability in younger adults and the most common cause of sudden death in young athletes. Researchers from the University of Alabama at Birmingham Marn . . .